Impact of a Tripartite Collaboration between Oncologist, Pharmacist and Diabetologist in the Management of Patients with Diabetes Starting Chemotherapy: The ONCODIAB Trial.
Justine ParisPauline LegrisMadeline DevauxStephanie BostPauline GueneauCedric RossiSylvain ManfrediBenjamin BouilletJean-Michel PetitPauline PistreMathieu BoulinPublished in: Cancers (2023)
In our study, a close collaboration between oncologists, pharmacists, and diabetologists helped by continuous glucose monitoring led to overall medication optimization and better glycemic control in patients with diabetes starting chemotherapy.